Search Within

Joachim Yahalom

  1. "Department of Medicine"
Formats
  1. Meeting Abstract (141)
  2. Journal Article (115)
  3. Book Section (17)
  4. Research Letter (5)
  5. Conference Paper (4)
  6. Review (1)
Groups
  1. Department of Medicine (283)
  2. Radiation Oncology, Department of (283)
  3. Survivorship Research (283)
  4. Hematologic Malignancies, Division of (277)
  5. Center for Hematologic Malignancies (243)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Craig Moskowitz (87)
  3. David Straus (82)
  4. Brandon Imber (73)
  5. Ariela Noy (71)
  6. Steven Horwitz (65)

More People

Years
  1. 2025 (3)
  2. 2024 (17)
  3. 2023 (33)
  4. 2022 (13)
  5. 2021 (15)
  6. 2020 (13)

More Years

Publications
  1. Blood (81)
  2. International Journal of Radiation Oncology, Biology, Physics (31)
  3. Hematological Oncology (24)
  4. Journal of Clinical Oncology (19)
  5. Journal of the National Comprehensive Cancer Network (19)
  6. British Journal of Haematology (9)

More Publications

Publishers
  1. American Society of Hematology (89)
  2. Elsevier Inc. (48)
  3. Wiley Blackwell (27)
  4. American Society of Clinical Oncology (19)
  5. Harborside Press (19)
  6. Nature Publishing Group (13)

More Publishers

Results (283)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NCCN guidelines insights: Hodgkin lymphoma, version 1.2018: Featured updates to the NCCN guidelines
    Journal Article

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Aoun, P.; Armand, P.; Bello, C. M.; Benitez, C. M.; Bierman, P. J.; Chen, R.; more...
    Journal of the National Comprehensive Cancer Network (2018)

    Fulltext@MSK | Save
  • The role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group
    Journal Article

    Constine, L. S.; Yahalom, J.; Ng, A. K.; Hodgson, D. C.; Wirth, A.; Milgrom, S. A.; Mikhaeel, N. G.; Eich, H. T.; Illidge, T.; Ricardi, U.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Chen, R. W.; Constine, L. S.; Courtien, A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma
    Journal Article

    Teckie, S.; Qi, S.; Chelius, M.; Lovie, S.; Hsu, M.; Noy, A.; Portlock, C.; Yahalom, J.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Early-stage mantle cell lymphoma: A retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG)
    Journal Article

    Dabaja, B. S.; Zelenetz, A. D.; Ng, A. K.; Tsang, R. W.; Qi, S.; Allen, P. K.; Hodgson, D.; Ricardi, U.; Hoppe, R. T.; Advani, R.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • A pilot study of brentuximab vedotin and AVD chemotherapy followed by 20 Gy involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R.; Budde, E.; Barr, P. M.; Batlevi, C. L.; Chen, R.; Constine, L. S.; Courtien, A. I.; Dandapani, S. V.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Dose and/or volume reduction using consolidation volume radiation therapy (CVRT) lowers dose to heart and lungs in early-stage Hodgkin lymphoma patients with bulky disease
    Meeting Abstract

    Yang, J. C.; Kumar, A.; Chapman, K. L.; Burleson, S.; Huang, C.; Constine, L. S.; Hoppe, R. T.; Dandapani, S.; Straus, D. J.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save